Statements (15)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Vifor_Pharma
|
| gptkbp:acquisitionYear |
2016
|
| gptkbp:focus |
cardiovascular and renal diseases
|
| gptkbp:foundedIn |
2007
|
| gptkbp:founder |
gptkb:Gerard_T._Burrow
|
| gptkbp:headquartersLocation |
gptkb:Redwood_City,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Relypsa
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:product |
gptkb:patiromer
|
| gptkbp:publiclyTraded |
yes
|
| gptkbp:status |
gptkb:subsidiary
|
| gptkbp:stockSymbol |
gptkb:RLYP
|
| gptkbp:bfsParent |
gptkb:Sofinnova_Investments
|
| gptkbp:bfsLayer |
6
|